Fudan University Shanghai Cancer Center

Shanghai · Onkologi · 3A

Fudan 2022 · #30 3A

Ikhtisar

Fudan University Shanghai Cancer Center adalah rumah sakit unggulan di Shanghai, Tiongkok. Rumah sakit ini masuk dalam 100 Besar MedTravelCN karena keunggulannya di bidang Onkologi dan kemampuannya menerima pasien internasional.

One of China's earliest dedicated cancer hospitals.

Informasi utama

Tahun berdiri1931
KotaShanghai
Spesialisasi unggulanOnkologi
Akreditasi3A
Peringkat Fudan 2022#30

Alamat & lokasi

No. 270 Dong'an Road, Xuhui District, Shanghai

Departemen unggulan

Surgical oncology Radiation oncology Medical oncology Pathology

Tren peringkat (peringkat Fudan, rentang referensi)

21-40
2021
11-20
2022
21-40
2023
21-40
2024
21-40
2025

Rentang disusun dari rilis peringkat Fudan 2021-2025, hanya sebagai referensi.

Dokter representatif

  • Shao Zhimin · Breast surgery; director of cancer institute
  • Guo Xiaomuo · President; radiation oncology
  • Yu Xianjun · Pancreatic surgery & oncology
  • Wu Jiong · Breast surgery
  • Hu Xichun · Medical oncology

Daftar ahli dari sumber publik dan situs resmi rumah sakit; ketersediaan dan jabatan dapat berubah — verifikasi ke rumah sakit sebelum memesan.

Berita & tonggak sejarah

2024

Breast MDT care and pancreatic-cancer research keep producing international outputs

2024

Breast MDT model spreads nationally

Shao Zhimin's breast MDT precision model spreads nationally, with subtype therapy entering consensus.

2024

Pancreatic cancer care keeps improving

Combined pancreatic treatment studies with medical and radiation oncology keep publishing internationally.

2023

Precision oncology center deepens

The precision oncology center advances genomics-guided care with a top national trial portfolio.

2022

Oncology ranks top two in Fudan list

In the Fudan specialty ranking, the hospital's oncology ranks top two nationally.

2022

Paired assistance and medical alliance support grassroots hospitals

Ongoing paired assistance and telemedicine collaboration upgrade grassroots capacity in breast surgery and beyond.

2024

A national base for residency training and medical talent

A major national residency training base, the hospital graduates large cohorts of residents, fellows and nurses under internationally aligned curricula.

2025

Clinical research and innovation keep accelerating

The hospital leads or joins numerous national multicenter trials, publishing in authoritative journals and translating findings into practice.

2025

International patient services keep improving

The international desk assists foreign patients with booking, interpretation, cost estimates and insurance, with streamlined workflows.

2022

Smart hospital and digital management recognized

Its smart service and management systems passed national reviews, improving integrated online-offline care.

2023

Nursing excellence and patient safety upgraded

Nursing quality and patient-safety programs were upgraded, with adverse-event monitoring and infection control meeting national standards.

2024

Medical education quality keeps improving

Expanded clinical skills centers apply simulation teaching and OSCE assessments widely.

2022

Regular charity clinics and health assistance

Expert teams regularly hold charity clinics in remote areas under a long-term assistance mechanism.

2024

Service scale and specialty breadth rank among the best

With high bed capacity and outpatient volumes, its dozens of specialties span breast surgery, pancreatic oncology and radiation oncology.

2025

Fudan University Shanghai Cancer Center upgrades multilingual international services

The international department offers multilingual consultations with record translation, test booking and admission coordination for overseas patients in breast surgery and related specialties.

2024

Fudan University Shanghai Cancer Center leads a specialty alliance to spread expertise

A specialty alliance built around breast surgery and pancreatic oncology spreads capacity through teleconsultation, two-way referral and standardised training.

2023

Centre for rare and complex diseases established

Bringing together breast surgery, radiation oncology and genetic counselling, the hospital shortens time to diagnosis for rare disease.

2022

Clinical pathways and quality management pass national review

Standardised pathways and single-disease quality control improved surgical safety and antimicrobial stewardship metrics.

2025

Research wards and innovative-drug trials expand

Research wards provide a regulated platform for drug and device trials, with eligibility assessment for patients.

2025

Fudan University Shanghai Cancer Center holds a top position in the Fudan China Hospital Ranking

In the latest Fudan China Hospital Ranking, Fudan University Shanghai Cancer Center holds a top-tier national position, with several specialties in the top specialty lists and a growing national referral volume.

2024

Cancer screening and precision therapy platforms improve

Screening and genomics-guided precision platforms keep improving, with a top national trial portfolio.

Tonggak dirangkum dari laporan publik tepercaya dan rilis resmi; judul adalah ringkasan.

Kerja sama internasional

  • Deep participation in international trial networks with globally referenced findings.
  • Breast and pancreatic experts serve in international oncology societies.
  • Early-phase trials run with international sponsors and research institutes.
  • Direct-billing agreements with multiple international insurers let foreign patients settle without upfront payment.
  • Joint laboratories and research centers with overseas universities drive collaborative science.
  • Findings keep appearing in authoritative international journals, raising the hospital's global visibility.
  • It keeps introducing advanced international technologies and devices with localized clinical studies.
  • Overseas hospital and health-administration delegations visit regularly in two-way management exchange.
  • Key staff are sent annually for advanced training at international oncology research networks, lifting departmental capability on return.
  • Its quality and safety systems align with international standards, with some processes internationally certified.
  • Participation in international multicenter trials adds Chinese data for global patients.
  • Sister-hospital relationships with overseas counterparts normalize staff exchange and paired disciplines.
  • Experts from the hospital contribute to international guidelines and consensus statements, cited by peers in international oncology research networks.
  • The international desk offers multilingual escort and record translation, easing communication for cross-border patients.
  • Cross-border referral channels offer remote assessment, travel planning and airport assistance for seriously ill patients.
  • Selected services hold international certification or join global collaborative networks, aligning practice with international standards.
  • Follow-up and health-management communities give overseas patients reminders, report interpretation and medication advice.
  • Faculty of Fudan University Shanghai Cancer Center serve on committees, boards and journal editorial teams internationally, contributing to global guidelines.
  • The hospital hosts international congresses with regular visiting speakers from international oncology research networks.
  • The hospital accepts international fellows; physicians from international oncology research networks have completed structured training here.

Informasi kerja sama dirangkum dari sumber publik; merujuk rilis resmi rumah sakit.

Kolaborasi universitas

Fudan University

Riset & publikasi

Leads multi-center trials in breast and colorectal cancer.

Dirangkum dari sumber publik (Oktober 2026). Cek situs resmi rumah sakit sebelum berangkat.

Baca proses perjalanan medis ← Kembali ke peringkat rumah sakit